Linitis Plastica: a Distinct Type of Gastric Cancer
The prognosis of patients with linitis plastica (LP) gastric cancer is reported to be poor. The purpose of our retrospective study was to characterize the clinicopathologic features and survival outcomes of patients with LP, using a univocal definition.
We defined LP as gastric cancer that involves more than 1/3 of the gastric wall macroscopically. We reviewed a prospectively maintained institutional database of gastric cancer patients and summarized and compared clinicopathologic factors of patients with and without LP who had undergone gastrectomy. Patients were matched 1:1 using propensity score matching, and their overall survival (OS) rates and durations were compared. Multivariable Cox regression analyses were conducted, using gastrectomy as a time-varying covariate.
We identified 740 patients with radiographically non-metastatic gastric cancer, 157 (21.2%) of whom had LP. Most patients with LP had advanced-stage disease (75.8% had stage IV disease, mainly due to peritoneal involvement). Patients with LP had significantly shorter OS durations than did those without LP in the entire cohort (median OS, 14.0 vs. 33.5 months; p value < 0.001) and in the surgical cohort (median OS after gastrectomy, 21.8 vs. 91.0 months; p < 0.001), as well as in the propensity-matched surgical cohort. In the LP cohort, chemotherapy (hazard ratio [HR] = 0.594; p = 0.076), chemoradiation therapy (HR = 0.346; p = 0.001), and gastrectomy (HR = 0.425; p = 0.003) were associated with a longer OS.
LP is a phenotype of gastric cancer that often presents at an advanced stage, with a high rate of peritoneal involvement. The survival durations of patients with LP were poor in our study, even in the surgical cohort. The use of preoperative chemotherapy, chemoradiation therapy, and gastrectomy appeared to be important in carefully selected patients with localized LP.
KeywordsLinitis plastica Gastric cancer Diffuse Signet ring Gastrectomy Borrmann type IV Scirrhous carcinoma
We thank the Department of Scientific Publications at MD Anderson for editorial assistance.
This study was supported in part by the National Institutes of Health under award number P30 CA016672 and by the Clinical Trials Support Resource.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflicts of interest.
- 1.Ferlay J, Soerjomataram I, Ervik M. GLOBOCAN, cancer incidence and mortality worldwide: IARC cancer base no. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. 2012.Google Scholar
- 18.Thompson RJ, Ranaghan L, Kennedy R, Clements W, Carey PD, Kennedy JA. Survival following operative management of gastric linitis plastica compared with non-operative management. Annals of the Royal College of Surgeons of England. 2016:1-5.Google Scholar
- 20.Edge S, Byrd D, Compton C, Fritz A, Greene F, Trotti A. Stomach. AJCC Cancer Staging Book 7th ed Berlin: Springer. 2010:145-152.Google Scholar
- 24.Ikoma N, Blum M, Estrella JS, et al. Left Gastric Artery Lymph Nodes Should Be Included in D1 Lymph Node Dissection in Gastric Cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2017.Google Scholar
- 27.Ikoma N, Blum M, Estrella JS, et al. Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2017.Google Scholar
- 29.John P. Klein MLM. Survival Analysis: Techniques for Censored and Truncated Data (Statistics for Biology and Health). Springer; 2005.Google Scholar
- 33.Thoemmes F. Propensity score matching in SPSS. arXiv preprint arXiv:12016385. 2012.Google Scholar
- 35.Terai S, Fushida S, Tsukada T, et al. Bone marrow derived “fibrocytes” contribute to tumor proliferation and fibrosis in gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2015;18(2):306-313.CrossRefGoogle Scholar